NCT03073668

Brief Summary

The researchers are doing this study to find out whether there will be less increase in cardiac filling pressure after the surgeon opens the pericardium (the membrane around the heart) than when the pericardium is intact. The researchers want to see whether opening the pericardium is an effective way to reduce the blood filling pressures in the heart.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable heart-failure

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 8, 2017

Completed
12 days until next milestone

Study Start

First participant enrolled

March 20, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2019

Completed
Last Updated

May 14, 2019

Status Verified

May 1, 2019

Enrollment Period

10 months

First QC Date

March 3, 2017

Last Update Submit

May 11, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Pulmonary Artery Wedge Pressure (PAWP)

    Patients will undergo induction with general anesthesia, and at baseline the chest will be open, but pericardium left intact. Cardiac hemodynamics will be measured using the Pulmonary Artery Catheter already in place. The surgical team will then perform anterior pericardiotomy, with removal of pericardial restraint, and cardiac hemodynamics will be measured again.

    Baseline, approximately 1 hour

Secondary Outcomes (2)

  • Change in Pulmonary Artery Pressure (PAP)

    Baseline, approximately 1 hour

  • Change in Right Arterial Pressure (RAP)

    Baseline, approximately 1 hour

Study Arms (1)

Heart Failure Patients

EXPERIMENTAL

After obtaining written informed consent, patients will undergo induction with general anesthesia as per clinical practice. The chest will be open but pericardium left intact. Cardiac hemodynamics will be measured using PA catheter already in place at rest, and then during conditions of increased cardiac preload, induced by passive leg elevation and saline bolus (300 ml administered over 1-2 minutes). The surgical team will perform anterior pericardiotomy. This will not be a complete pericardiectomy but rather a limited anterior incision to gain access to the heart for surgical exposure. The surgical team will then repeat hemodynamic assessments at rest and with acute volume loading (leg raise + saline) in exactly the same manner as with the pericardium intact.

Procedure: Anterior pericardiotomyDrug: Saline

Interventions

The surgical team will perform anterior pericardiotomy. This will not be a complete pericardiectomy but rather a limited anterior incision to gain access to the heart for surgical exposure.

Heart Failure Patients
SalineDRUG

During the measurement of cardiac hemodynamic tests, a saline bolus of 300 ml will be administered over 1-2 minutes.

Heart Failure Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>17 years old
  • Subjects having open sternotomy for either aortic valve stenosis or coronary artery bypass grafting (or both)
  • \<18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Conditions

Heart Failure

Interventions

Sodium Chloride

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Barry A Borlaug

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine, College of Medicine

Study Record Dates

First Submitted

March 3, 2017

First Posted

March 8, 2017

Study Start

March 20, 2017

Primary Completion

January 23, 2018

Study Completion

February 2, 2019

Last Updated

May 14, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations